Session 14: Evidence-Based Approaches to Clinical Pathway Development for Metastatic Urothelial Cancer

Learning Objectives:

• Describe the clinical challenges and unmet needs associated with treatment selection and management of mUC
• Evaluate the safety, efficacy, and cost-effectiveness data associated with available first-, second, and subsequent-line therapies for mUC
• Tailor clinical pathways to incorporate evidence-based and patient-centered care strategies to address treatment selection and sequencing, treatment barriers, adherence, adverse events, and costs